Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paige E Selvy

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Chemical Reviews|September 23, 2011
Phospholipase D: enzymology, functionality, and chemical modulationPaige E Selvy, Robert R Lavieri, Craig W Lindsley, et al.
Bioorganic & Medicinal Chemistry Letters|March 21, 2009
Design and synthesis of isoform-selective phospholipase D (PLD) inhibitors. Part II. Identification of the 1,3,8-triazaspiro[4,5]decan-4-one privileged structure that engenders PLD2 selectivityRobert Lavieri, Sarah A Scott, Jana A Lewis, et al.
Biochemistry|January 17, 2009
Evidence that alpha-synuclein does not inhibit phospholipase DIrit Rappley, Aaron D Gitler, Paige E Selvy, et al.
Journal of Medicinal Chemistry|August 26, 2010
Design, synthesis, and biological evaluation of halogenated N-(2-(4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]decan-8-yl)ethyl)benzamides: discovery of an isoform-selective small molecule phospholipase D2 inhibitorRobert R Lavieri, Sarah A Scott, Paige E Selvy, et al.
Bioorganic & Medicinal Chemistry Letters|March 10, 2009
Design and synthesis of isoform-selective phospholipase D (PLD) inhibitors. Part I: Impact of alternative halogenated privileged structures for PLD1 specificityJana A Lewis, Sarah A Scott, Robert Lavieri, et al.
Nature Chemical Biology|January 13, 2009
Design of isoform-selective phospholipase D inhibitors that modulate cancer cell invasivenessSarah A Scott, Paige E Selvy, Jason R Buck, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Chemical Reviews|September 23, 2011
Phospholipase D: enzymology, functionality, and chemical modulationPaige E Selvy, Robert R Lavieri, Craig W Lindsley, et al.
Bioorganic & Medicinal Chemistry Letters|March 21, 2009
Design and synthesis of isoform-selective phospholipase D (PLD) inhibitors. Part II. Identification of the 1,3,8-triazaspiro[4,5]decan-4-one privileged structure that engenders PLD2 selectivityRobert Lavieri, Sarah A Scott, Jana A Lewis, et al.
Biochemistry|January 17, 2009
Evidence that alpha-synuclein does not inhibit phospholipase DIrit Rappley, Aaron D Gitler, Paige E Selvy, et al.
Journal of Medicinal Chemistry|August 26, 2010
Design, synthesis, and biological evaluation of halogenated N-(2-(4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]decan-8-yl)ethyl)benzamides: discovery of an isoform-selective small molecule phospholipase D2 inhibitorRobert R Lavieri, Sarah A Scott, Paige E Selvy, et al.
Bioorganic & Medicinal Chemistry Letters|March 10, 2009
Design and synthesis of isoform-selective phospholipase D (PLD) inhibitors. Part I: Impact of alternative halogenated privileged structures for PLD1 specificityJana A Lewis, Sarah A Scott, Robert Lavieri, et al.
Nature Chemical Biology|January 13, 2009
Design of isoform-selective phospholipase D inhibitors that modulate cancer cell invasivenessSarah A Scott, Paige E Selvy, Jason R Buck, et al.
Pageof 1